First human tests begin for new oral drug candidate
Knowledge-focused
Completed
This early-stage study aimed to check the safety of a new oral liquid drug called BIO 300 and learn how the body absorbs and processes it. It involved 56 healthy volunteers who took the drug daily for two weeks at different doses. A second part tested whether taking the drug with…
Phase: PHASE1 • Sponsor: Humanetics Corporation • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC